Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax is a research paper published in Bioorganic & Medicinal Chemistry Letters (2021). On theSindex it has a DataRank of 0.612. It has been cited 58 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.612
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: CA251151
National Institutes of Health
Grant: CA036727
National Institutes of Health
Grant: CA197999
National Institutes of Health
Grant: GM121316
NIGMS NIH HHS
Grant: P20 GM121316
NCI NIH HHS
Grant: R21 CA251151
NCI NIH HHS
Grant: P30 CA036727
NCI NIH HHS
Grant: R01 CA197999
National Institutes of Health
Grant: 5P20GM121316-03
Nebraska Center for Molecular Target Discovery and Development
National Institutes of Health
Grant: 1R21CA251151-01
PROTACs for pancreatic cancer therapy
European Commission
Grant: 251151
Integration of Biology and Engineering into an Economical and Energy-Efficient 2G Bioethanol Biorefinery
National Institutes of Health
Grant: 5R01CA197999-08
Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers
University of Nebraska Medical Center
FWCI
3.13
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals